dQ&A launched the beta of our next-gen AI Insights Platform—a breakthrough natural language solution providing instant, data-driven answers for the diabetes market.
Together with our community members and employees, we have contributed over $5,000 to support people with diabetes in Ukraine.
We are excited to announce dQ&A’s new syndicated qualitative research service, First Look Insights.
This white paper outlines how psychographics reveal the drivers behind diabetes patient behaviors, helping predict actions and guide better decisions.
This survey shows COVID-19 booster rates are higher in U.S. adults with diabetes than the general population, but vary by race, income, and location.
We surveyed panel members about the FDA advisory on Provention Bio’s teplizumab to delay type 1 diabetes—discover their top concerns and expected impact.
This research reveals how stigma in diabetes—from HCPs and society—affects relationships, care decisions, mental health, and diabetes management.
ADA and dQ&A survey results reveal that COVID fears kept one in five people with diabetes away from the doctor during the pandemic.
Which diabetes groups lead or lag on COVID-19 shots? See dQ&A’s panel results from March 2021 and uncover barriers to higher coverage.
